Campus Recreation program gives free access to virtual workouts from colleges across country
Join the 2020 Recreation Movement - Sign up, workout, log your activity to compete
Want to try a Barre class from Stanford? How about Body Pump from Wake Forest University?
Join the 2020RecreationMovement and get moving! The program encourages participants to exercise and compete against universities across the country to see who is the most active.
In addition, participants can take advantage of virtual workouts from more than 100 colleges and universities.
Signing up is easy. Create an account using your .edu email address and instantly access live and prerecorded workout, fitness and movement classes. Take a class, or go for a walk and then log your active minutes. Every active minute counts! Watch as University of Cincinnati's total minutes stack up against other participating schools.
Recreation Movement is organized by NIRSA, the governing body for UC Campus Recreation. Join the UC community to move every day, stay healthy and be well.
Related Stories
UC faculty and staff among Rising Star leadership honorees
January 5, 2026
Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.